Clinical pharmacokinetics of the BCR-ABL tyrosine kinase inhibitor nilotinib. [electronic resource]
Producer: 20100218Description: 197-203 p. digitalISSN:- 1532-6535
- Administration, Oral
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Area Under Curve
- Dietary Fats
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Food-Drug Interactions
- Fusion Proteins, bcr-abl -- administration & dosage
- Humans
- Leukocyte Count
- Male
- Middle Aged
- Protein-Tyrosine Kinases -- administration & dosage
- Pyrimidines -- administration & dosage
- Solubility
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.